Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Healthcare Biotechnology
Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United... see more

Recent & Breaking News (TSXV:MPH)

Medicure Announces Early Completion of Enrollment for iSPASM, a Phase 1/2a Exploratory Clinical Trial of AGGRASTAT® (tirofiban hydrochloride) Injection vs. Placebo for Induced Suppression of Platelets Activity in Aneurysmal Subarachnoid Hemorrhage Management

Canada NewsWire January 27, 2021

Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for Treatment of Seizures Associated with Pyridox(am)ine 5'-phosphate oxidase (PNPO) Deficiency

Canada NewsWire January 7, 2021

Medicure Enters the US Online Pharmacy World with Acquisition of Marley Drug

PR Newswire December 17, 2020

Medicure Retains Investor Relations Firm Renmark Financial Communications Inc.

PR Newswire December 2, 2020

Medicure Announces Settlement of Patent Infringement Action

Canada NewsWire November 18, 2020

Medicure Reports Financial Results for Quarter Ended September 30, 2020

Canada NewsWire November 11, 2020

Medicure Q3 2020 Results and Conference Call Dates

Canada NewsWire November 5, 2020

Medicure announces an agreement with Reliance Life Sciences for the marketing rights of a cardiovascular biosimilar

Canada NewsWire October 5, 2020

Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports

Canada NewsWire August 24, 2020

Medicure Announces Termination of ReDSTM Pro Marketing and Distribution Agreement

Canada NewsWire August 20, 2020

Medicure Reports Financial Results for Quarter Ended June 30, 2020

Canada NewsWire August 11, 2020

Medicure Q2 2020 Results and Conference Call Dates

Canada NewsWire August 5, 2020

Medicure Announces Normal Course Issuer Bid

Canada NewsWire June 29, 2020

Medicure Announces Positive Results for AGGRASTAT® in the FABOLUS-FASTER Trial and Publication in the Journal - Circulation

Canada NewsWire June 29, 2020

Medicure Announces a Direct to Patient Online Pharmacy Program for Distribution of ZYPITAMAG(TM) (Pitavastatin) Tablets

Canada NewsWire June 25, 2020

C-Suite At The Open: Albert Friessen, Chair & CEO from Medicure Inc. tells his Company story. Filmed May 2020.

Canada NewsWire June 18, 2020

Medicure Announces Top Line Data from FABOLUS-FASTER Trial With AGGRASTAT® will be Presented at the PCR e-Course, Late Breaking Trial Sessions, June 27, 2020

Canada NewsWire June 15, 2020

Medicure Reports Financial Results for Quarter Ended March 31, 2020

Canada NewsWire May 12, 2020

Medicure Q1 2020 results and conference call dates

Canada NewsWire May 6, 2020

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2019

PR Newswire April 15, 2020